Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics società ha sostenuto
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leggi di più
KPTI is an amazing firm comprised of driven, engaged and bright employees. I am happy at KPTI but worried about my performance. I am new to this industry and KPTI and the adjustment has not been easy.
Cosa ti piace di più del team di leadership?
They are responsive, accessible and enthusiastic.
Qual è la parte migliore del tuo compenso?
The secondary plan that helps cover health care deductibles.
Quali sono alcune delle cose migliori della tuo team?
They are invested in KPTI and work very hard.
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
Employees are engaged and invested.
Che cosa ti rende più felice sul posto di lavoro?
The every day challenges because so many processes are being developed.
Other Employee Reviews for Karyopharm Therapeutics
×